| Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population … A Cassini, LD Högberg, D Plachouras, A Quattrocchi, A Hoxha, ... The Lancet infectious diseases 19 (1), 56-66, 2019 | 2975 | 2019 |
| The sheddase ADAM10 is a potent modulator of prion disease HC Altmeppen, J Prox, S Krasemann, B Puig, K Kruszewski, F Dohler, ... Elife 4, e04260, 2015 | 97 | 2015 |
| Description of the first global outbreak of mpox: an analysis of global surveillance data H Laurenson-Schafer, N Sklenovská, A Hoxha, SM Kerr, P Ndumbi, ... The Lancet Global Health 11 (7), e1012-e1023, 2023 | 69 | 2023 |
| Challenges in interpreting SARS-CoV-2 serological results in African countries AN Ndaye, A Hoxha, J Madinga, J Mariën, M Peeters, FH Leendertz, ... The Lancet Global Health 9 (5), e588-e589, 2021 | 69 | 2021 |
| Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012–2013 A Hoxha, T Kärki, C Giambi, C Montano, A Sisto, A Bella, F D'Ancona, ... Journal of Hospital Infection 92 (1), 61-66, 2016 | 59 | 2016 |
| Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities A Hoxha, C Wyndham-Thomas, S Klamer, D Dubourg, M Vermeulen, ... The Lancet Infectious Diseases 21 (4), e67, 2021 | 54 | 2021 |
| Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–2017 R Bruyndonckx, A Hoxha, C Quinten, GM Ayele, S Coenen, A Versporten, ... Journal of Antimicrobial Chemotherapy 76 (Supplement_2), ii68-ii78, 2021 | 13 | 2021 |
| E Kretzschmar, M.; Devleesschauwer, B.; Cecchini, M.; et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in … A Cassini, LD Högberg, D Plachouras, A Quattrocchi, A Hoxha, ... Lancet Infect. Dis 19, 56-66, 2019 | 11 | 2019 |
| Healthcare-associated infections in home healthcare: an extensive assessment, 2019 A Hoxha, E Duysburgh, L Mortgat Eurosurveillance 26 (5), 1900646, 2021 | 10 | 2021 |
| Mpox in children and adolescents during multicountry outbreak, 2022–2023 A Hoxha, SM Kerr, H Laurenson-Schafer, N Sklenovská, BB Mirembe, ... Emerging Infectious Diseases 29 (10), 2125, 2023 | 3 | 2023 |
| Emergency committee recommendations on mpox–what’s next? RF Lewis, K Kuppalli, A Hoxha, MC Doherty Bulletin of the World Health Organization 101 (5), 300, 2023 | 3 | 2023 |
| The sheddase ADAM10 significantly impacts on prion disease H Altmeppen, J Prox, S Krasemann, B Puig, K Kruszewski, F Dohler, ... PRION 9, S6-S6, 2015 | | 2015 |
| Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012e2013 A Hoxha, T Kärki, C Giambi, C Montano, A Sisto, A Bella Journal of Hospital Infection 30, 1e6, 2015 | | 2015 |
| Temporary Adaptations to Sexual Behaviour During the Mpox Outbreak in Europe and the Americas: Findings from an Online Survey in 23 Countries M Prochazka, PLG Vinti, A Hoxha, A Seale, A Mozalevskis, RF Lewis, ... Available at SSRN 4845170, 0 | | |
| Global Analysis of the 2022-2023 Mpox Outbreak: Demographics, Clinical Features, and Risk Factors for Hospitalization H Laurenson-Schafer, S Kerr, GS Tuncer, P Ndumbi, BB Mirembe, ... 9TH INTERNATIONAL CONFERENCE ON INFECTIOUS DISEASE DYNAMICS P 2, 0 | | |